0001562180-23-006837.txt : 20230913
0001562180-23-006837.hdr.sgml : 20230913
20230913160134
ACCESSION NUMBER: 0001562180-23-006837
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230911
FILED AS OF DATE: 20230913
DATE AS OF CHANGE: 20230913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cardama Alfonso Quintas
CENTRAL INDEX KEY: 0001760104
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 231252649
MAIL ADDRESS:
STREET 1: C/O TCR2 THERAPEUTICS INC.
STREET 2: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-09-11
false
0001822462
Foghorn Therapeutics Inc.
FHTX
0001760104
Cardama Alfonso Quintas
500 TECHNOLOGY SQUARE
SUITE 700
CAMBRIDGE
MA
02139
false
true
false
false
Chief Medical Officer
false
Stock Options (Right to buy)
7.57
2023-09-11
4
A
false
272000.00
7.57
A
2033-09-10
Common Stock
272000.00
272000.00
D
The option vests as to 25% of the underlying shares of common stock on September 11, 2024, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.
/s /Allan Reine, M.D., Attorney-in-Fact
2023-09-13